Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HAYTHEM Y ALI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1174691695
CMS profile
98962
Location
DETROIT, MI

General Payments · PY2018–2024

$35,552.64

  • Reported across 122 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,868.27

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
AstraZeneca UK Limited $2,017.44 12
Acerta Pharma LLC $1,717.44 3
PFIZER INC. $1,440.00 1
NOVARTIS PHARMACEUTICALS CORPORATION $398.80 4
Daiichi Sankyo Inc. $144.20 2
Tempus AI, Inc $79.61 1
PUMA BIOTECHNOLOGY, INC. $54.19 1
Gilead Sciences, Inc. $16.59 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,670.27 20
PY2019 $8,580.42 29
PY2020 $2,642.10 9
PY2021 $4,925.92 5
PY2022 $3,499.36 6
PY2023 $7,366.30 28
PY2024 $5,868.27 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $250.00 01/30/2024 Grant Undisputed 01/23/2026 1110535870 CMS
AstraZeneca Pharmaceuticals LP $102.44 04/23/2024 Food and Beverage Undisputed 01/23/2026 1110536504 CMS
AstraZeneca Pharmaceuticals LP $1,365.00 06/25/2024 Consulting Fee Undisputed 01/23/2026 1110541773 CMS
AstraZeneca UK Limited $59.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110533260 CMS
AstraZeneca UK Limited $70.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110539581 CMS
AstraZeneca UK Limited $120.54 01/30/2024 Travel and Lodging Undisputed 01/23/2026 1110540543 CMS
AstraZeneca UK Limited $60.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110543251 CMS
AstraZeneca UK Limited $70.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110546627 CMS
AstraZeneca UK Limited $135.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110547116 CMS
AstraZeneca UK Limited $631.99 01/30/2024 Travel and Lodging Undisputed 01/23/2026 1110547552 CMS
AstraZeneca UK Limited $584.68 01/30/2024 Travel and Lodging Undisputed 01/23/2026 1110549122 CMS
AstraZeneca UK Limited $60.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110549234 CMS
AstraZeneca UK Limited $61.23 01/30/2024 Travel and Lodging Undisputed 01/23/2026 1110550336 CMS
AstraZeneca UK Limited $30.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110553068 CMS
AstraZeneca UK Limited $135.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110554766 CMS
Daiichi Sankyo Inc. $44.45 07/18/2024 Food and Beverage Undisputed 01/23/2026 1089392566 CMS
Daiichi Sankyo Inc. $99.75 08/06/2024 Food and Beverage Undisputed 01/23/2026 1089392578 CMS
Gilead Sciences, Inc. $16.59 08/30/2024 Food and Beverage Undisputed 01/23/2026 1133831877 CMS
Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086741887 CMS
Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086741889 CMS
Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086741883 CMS
Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086741885 CMS
PFIZER INC. $1,440.00 05/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132011132 CMS
PUMA BIOTECHNOLOGY, INC. $54.19 06/19/2024 Food and Beverage Undisputed 01/23/2026 1113837683 CMS
Tempus AI, Inc $79.61 09/18/2024 Food and Beverage Undisputed 01/23/2026 1150160126 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.